Low-risk and very-low-risk prostate cancer: is there a role for focal therapy in the era of active surveillance? Yes, the two approaches complement each other.
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Laurence
L
Klotz
Thomas J
TJ
Polascik
D014408:Biomarkers, Tumor / Q000032:analysis; D006801:Humans; D008297:Male; D060787:Neoplasm Grading; D059351:Organ Sparing Treatments; D018579:Patient Selection; D011159:Population Surveillance; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D018570:Risk Assessment; D057832:Watchful Waiting
D014408:Biomarkers, Tumor